Pharmacy Practice & Science Department Highlights: April 2024

May 1, 2024
A pharmacist speaking with a patient during a health fair.

 

Publications

Ivo Abraham
MacDonald K, Pondel, Abraham I. Cost-efficiency and budget-neutral expanded access modeling of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal cancer. Journal of Medical Economics 2024;27(Suppl 3):1-8